These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36098049)

  • 1. Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort.
    Welsh P; Campbell RT; Mooney L; Kimenai DM; Hayward C; Campbell A; Porteous D; Mills NL; Lang NN; Petrie MC; Januzzi JL; McMurray JJV; Sattar N
    Circ Heart Fail; 2022 Oct; 15(10):e009427. PubMed ID: 36098049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort.
    Welsh P; Kimenai DM; Marioni RE; Hayward C; Campbell A; Porteous D; Mills NL; O'Rahilly S; Sattar N
    Clin Chem Lab Med; 2022 Oct; 60(11):1820-1829. PubMed ID: 35976089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
    Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
    Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
    Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
    JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.
    Suthahar N; Meijers WC; Ho JE; Gansevoort RT; Voors AA; van der Meer P; Bakker SJL; Heymans S; van Empel V; Schroen B; van der Harst P; van Veldhuisen DJ; de Boer RA
    Eur J Heart Fail; 2018 Aug; 20(8):1205-1214. PubMed ID: 29855124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.
    Jafri L; Kashif W; Tai J; Siddiqui I; Azam I; Shahzad H; Ghani F
    BMC Nephrol; 2013 May; 14():117. PubMed ID: 23725445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
    deFilippi CR; Christenson RH; Gottdiener JS; Kop WJ; Seliger SL
    J Am Coll Cardiol; 2010 Feb; 55(5):441-50. PubMed ID: 20117457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum.
    Faxén UL; Lund LH; Orsini N; Strömberg A; Andersson DC; Linde C; Dahlström U; Savarese G
    Int J Cardiol; 2019 Jul; 287():66-72. PubMed ID: 31005415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
    Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum N-terminal pro-brain natriuretic peptide in normal Thai subjects.
    Leowattana W; Sirithunyanont C; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Kangkagate C; Mahanonda N; Bhuripanyo K
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S46-51. PubMed ID: 12866768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
    Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
    Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events　- The Japan Morning Surge-Home Blood Pressure Study.
    Taki M; Ishiyama Y; Mizuno H; Komori T; Kono K; Hoshide S; Kario K
    Circ J; 2018 Jul; 82(8):2096-2102. PubMed ID: 29925742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction.
    Januzzi JL; Tan X; Yang L; Brady JE; Yang M; Banka P; Lautsch D
    ESC Heart Fail; 2022 Feb; 9(1):87-99. PubMed ID: 34918487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
    Ezekowitz JA; O'Connor CM; Troughton RW; Alemayehu WG; Westerhout CM; Voors AA; Butler J; Lam CSP; Ponikowski P; Emdin M; Patel MJ; Pieske B; Roessig L; Hernandez AF; Armstrong PW
    JACC Heart Fail; 2020 Nov; 8(11):931-939. PubMed ID: 33039447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Pro-B-Type Natriuretic Peptide Is Not a Significant Predictor of Stroke Incidence After 5 Years　- The Ohasama Study.
    Satoh M; Murakami T; Asayama K; Hirose T; Kikuya M; Inoue R; Tsubota-Utsugi M; Murakami K; Matsuda A; Hara A; Obara T; Kawasaki R; Nomura K; Metoki H; Node K; Imai Y; Ohkubo T
    Circ J; 2018 Jul; 82(8):2055-2062. PubMed ID: 29887544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.
    Tan ESJ; Chan SP; Liew OW; Chong JPC; Gerard Leong KT; Daniel Yeo PS; Ong HY; Jaufeerally F; Sim D; Ling LH; Lam CSP; Richards AM
    JACC Heart Fail; 2024 Mar; 12(3):461-474. PubMed ID: 37897459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
    Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
    Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population.
    Lee KH; Kim JY; Koh SB; Lee SH; Yoon J; Han SW; Park JK; Choe KH; Yoo BS
    Korean Circ J; 2010 Dec; 40(12):645-50. PubMed ID: 21267387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.